ArticleJournal of medicinal chemistry2026
Nucleotide-Derived Competitive Inhibitors of Ectonucleotidase CD39─A Promising Extracellular Target for Immunotherapy of Cancer.
Chunyang Bi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.